These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16783599)

  • 1. Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors.
    Miguet L; Zhang Z; Barbier M; Grigorov MG
    J Comput Aided Mol Des; 2006 Feb; 20(2):67-81. PubMed ID: 16783599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
    Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening.
    Schuster D; Maurer EM; Laggner C; Nashev LG; Wilckens T; Langer T; Odermatt A
    J Med Chem; 2006 Jun; 49(12):3454-66. PubMed ID: 16759088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
    Yang H; Dou W; Lou J; Leng Y; Shen J
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Tu H; Powers JP; Liu J; Ursu S; Sudom A; Yan X; Xu H; Meininger D; Degraffenreid M; He X; Jaen JC; Sun D; Labelle M; Yamamoto H; Shan B; Walker NP; Wang Z
    Bioorg Med Chem; 2008 Oct; 16(19):8922-31. PubMed ID: 18789704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275.
    Siu M; Johnson TO; Wang Y; Nair SK; Taylor WD; Cripps SJ; Matthews JJ; Edwards MP; Pauly TA; Ermolieff J; Castro A; Hosea NA; LaPaglia A; Fanjul AN; Vogel JE
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3493-7. PubMed ID: 19473839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.
    Wan ZK; Chenail E; Xiang J; Li HQ; Ipek M; Bard J; Svenson K; Mansour TS; Xu X; Tian X; Suri V; Hahm S; Xing Y; Johnson CE; Li X; Qadri A; Panza D; Perreault M; Tobin JF; Saiah E
    J Med Chem; 2009 Sep; 52(17):5449-61. PubMed ID: 19673466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of important chemical features of 11β-hydroxysteroid dehydrogenase type1 inhibitors: application of ligand based virtual screening and density functional theory.
    Sakkiah S; Meganathan C; Sohn YS; Namadevan S; Lee KW
    Int J Mol Sci; 2012; 13(4):5138-5162. PubMed ID: 22606035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Vicker N; Su X; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):123-9. PubMed ID: 17482805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2.
    Yamaguchi H; Akitaya T; Yu T; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Ryoyama K
    Eur J Med Chem; 2011 Apr; 46(4):1325-30. PubMed ID: 21333409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1).
    Sun D; Wang Z; Di Y; Jaen JC; Labelle M; Ma J; Miao S; Sudom A; Tang L; Tomooka CS; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3513-6. PubMed ID: 18511278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
    J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type I.
    Valeur E; Christmann-Franck S; Lepifre F; Carniato D; Cravo D; Charon C; Bozec S; Musil D; Hillertz P; Doare L; Schmidlin F; Lecomte M; Schultz M; Roche D
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5909-14. PubMed ID: 22901389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery.
    Thomas MP; Potter BV
    Future Med Chem; 2011 Mar; 3(3):367-90. PubMed ID: 21446847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Su X; Vicker N; Trusselle M; Halem H; Culler MD; Potter BV
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):169-73. PubMed ID: 18775471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
    Lee JH; Kang NS; Yoo SE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
    Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV
    ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes.
    Zhang J; Osslund TD; Plant MH; Clogston CL; Nybo RE; Xiong F; Delaney JM; Jordan SR
    Biochemistry; 2005 May; 44(18):6948-57. PubMed ID: 15865440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.